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Chronic active Epstein-Barr virus (EBV) disease (CAEBV) is a systemic EBV-positive 
lymphoproliferative disorder characterized by fever, lymphadenopathy, and 
splenomegaly. Patients with CAEBV may present with cutaneous symptoms including 
hypersensitivity to mosquito bites and hydroa vacciniforme (HV)-like eruptions. HV is a 
rare photodermatosis characterized by vesicles and crust formation after exposure to 
sunlight, with onset in childhood, and is associated with latent EBV infection. While  T 
cells have been recently demonstrated to be the major EBV-infected cell population in 
HV, the immunophenotypic features of EBV-infected  T cells in CAEBV with HV-like 
eruptions or HV remain largely undetermined. Herein we describe 3 patients with 
CAEBV whose  T cells were found to be the major cellular target of EBV. HV-like 
eruptions were observed in two of them. A clonally expanded subpopulation of  T cells 
that were highly activated and T-cell receptor V9- and V2-positive cells was 
demonstrated in all patients. We also showed that the clonally expanded  T cells 
infiltrated into the HV-like eruptions in one patient from whom skin biopsy specimens 
were available. These results suggest the pathogenetic roles of clonally expanded  T 
cells infected by EBV in patients with CAEBV and HV-like eruptions. 
 





Epstein Barr virus (EBV) is a herpes virus that is ubiquitous in the human 
population. Primary EBV infection occasionally causes infectious mononucleosis that is 
an acute and usually benign self-limited disease [1]. The target of EBV infection is 
primarily B lymphocytes. However, EBV infection has also been etiologically associated 
with various malignancies and lymphoproliferative disorders including chronic active 
EBV infection (CAEBV), in which monoclonal or oligoclonal proliferation of EBV-
infected T or natural killer (NK) cells may play important roles in disease development 
[2]. CAEBV is characterized by persistent or recurrent infectious mononucleosis-like 
symptoms such as fever, lymphadenopathy and hepatosplenomegaly, and by extremely 
high viral loads in peripheral blood [3]. Patients with CAEBV may also suffer from 
cutaneous lesions including hypersensitivity to mosquito bites or hydroa vacciniforme 
(HV)-like eruptions. Based on the cellular targets of EBV, CAEBV can be divided into 
T-cell type and NK-cell type infections [4]. T-cell type CAEBV is further subdivided into 
CD4+, CD8+, and  T cell-type infections. 
HV is a rare photosensitivity disorder characterized by vesicle, crust and scar 
formation on sun-exposed areas with onset in childhood. Although the origin of this 
condition remains unknown, HV resolves spontaneously by adulthood in most cases [5]. 
However, there also have been severe cases accompanied by systemic manifestations 
including fever, lymphadenopathy and liver dysfunction. These patients may progress to 
cutaneous T-cell lymphoma [6]. Accumulating evidence has suggested that both typical 
and severe HV are associated with latent EBV infection [7-9]. In addition,  T cells have 
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recently been demonstrated to be the major cellular target of EBV infection in HV [10-
12]. However, the immunophenotypic features of EBV-infected  T cells and their 
involvement in skin lesions in CAEBV and/or HV are not fully understood. In this report, 
we describe 3 patients with CAEBV whose  T cells were predominantly infected by 





Materials and Methods 
 
Patients 
We evaluated 3 Japanese patients with  T cell-type CAEBV. The clinical and 
immunological data of patient 1 have been reported elsewhere [13]. Patient 2 was a 10-
year-old girl who had frequent episodes of fever, stomatitis, and liver dysfunction since 
the age of 4 years. She had mild hepatosplenomegaly. The copy numbers of the EBV 
genome were found to be extremely high in the peripheral blood at the age of 9 years (1.2 
x105 copies/g DNA). There was no history of hypersensitivity to mosquito bites and HV 
in this patient. Patient 3 was a 14-year-old female who developed vesiculopapules on 
sun-exposed skin at the age of 4 years. A diagnosis of HV was made at the age of 5 years, 
when skin biopsy specimens exhibited the presence of EBV genome. The EBV viral 
loads in the peripheral blood were in the range of 3.5 x 103 to 5.4 x104 copies/g DNA. 
Despite the absence of hepatosplenomegaly or lymphadenopathy, her clinical history was 
remarkable for occasional febrile episodes and frequent severe gingivitis in addition to 
HV. Approval for the study was obtained from the Human Research Committee of 
Kanazawa University Graduate School of Medical Science, and informed consent was 
provided according to the Declaration of Helsinki. 
 
Cell preparations and in situ hybridization for EBV-encoded small RNA1 (EBER-1) 
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque 
gradient centrifugation from patients and controls. Peripheral blood lymphocytes (PBLs) 
were prepared from PBMCs by depletion of monocytes using anti-CD14 monoclonal 
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antibody (mAb)-coated magnetic beads. CD4+ T, CD8+ T, CD19+ B, and CD56+ NK cells 
were then purified by positive selection from PBLs using mAb-coated magnetic beads 
[14]. To obtain  T cells, PBLs were stained with biotin-conjugated anti-T-cell receptor 
(TCR)  mAb, followed by incubation with streptavidin-coated magnetic beads (all from 
Becton Dickinson, San Diego, CA). The purity of the isolated , CD4+, and CD8+ T 
cells from patient 2 was 95.6, 98.6, and 97.8%, respectively, as determined by flow 
cytometric analysis. The purity of the isolated  T, CD4+ T, CD8+ T, CD19+ B, and 
CD56+ NK cells from patient 3 was 98.2, 98.4, 94.7, 96.2, and 92.8%, respectively. In 
situ hybridization for EBER-1 was performed as described previously [14]. 
 
Flow cytometry 
Expression of V chains and human leukocyte antigen (HLA)-DR was evaluated 
on  T cells using a FACSCalibur flow cytometer with CellQuest software (BD 
Bioscience, Tokyo, Japan) [14]. The following mAbs were used: fluorescein 
isothiocyanate-conjugated anti-TCR V1 (Thermo Scientific, Rockford, IL), anti-TCR 
V2 (Immunotech, Marseille, France), anti-TCR Pan  (Immunotech), and 
phycoerythrin-labled anti-HLA-DR (Becton Dickinson). 
 
Analysis of TCR V and V mRNA 
Complementarity determining region 3 (CDR3) spectratyping was performed as 
described previously, with minor modifications [15, 16]. Briefly, each fragment of TCR 
V and V was amplified from cDNA obtained from PBMCs with one of 3 V-specific 
or 3 V-specific primers, respectively. Thirty-five or 30 cycles of amplification (94˚C for 
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45 sec, 60˚C for 45 sec, and 72˚C for 45 sec) were used, and the polymerase chain 
reaction (PCR) products were then subjected to run-off reactions using a nested 6-
fluorescein phosphoramidite-labelled C or C primer, respectively. The size distribution 
of each of the fluorescent PCR products was determined as described previously [17]. 
Quantitative reverse-transcription (RT)-PCR of TCR V2 was performed on an ABI 7700 
Sequence Detection System (Applied Biosystems, Foster City, CA) using the SYBR 
GreenER qPCR SuperMix for ABI Prism (Invitrogen, Carlsbad, CA) [14]. We used -
actin as the reference gene. The PCR products of V2 cDNA were subcloned with a 
TOPO TA cloning kit (Invitrogen) and subcloned PCR products were sequenced using 
the ABI Prism BigDye Terminator Cycle Sequencing Kit on an ABI 3100 automated 
sequencer (Applied Biosystems). 
 
Analysis of TCR V genomic sequences in skin 
TCR- gene rearrangements were detected by family-specific multiplex PCR, as 
described previously [18]. Genomic DNA extracted from paraffin-embedded skin biopsy 
specimens with DEXPAT (Takara Bio Inc., Shiga, Japan) was subjected to PCR 
amplification using 6 TCR V-specific forward primers and 4 TCR J-specific reverse 
primers that could detect all major D(D)J rearrangements. PCR products were then 





Ectopic EBV infection of  T cells 
To determine which populations of lymphocytes were infected with EBV, in situ 
hybridization for EBER-1 was performed on samples isolated from the patients. As 
shown in Fig. 1,  T cells were found to account for the majority of EBER-1+ cells, with 
negligible EBER-1 identified in CD4+ T, CD8+ T, CD19+ B, and CD56+ NK cells in all 
cases. Immunophenotypic analysis of lymphocyte subsets exhibited markedly increased 
percentages of  T cells in their peripheral blood (Fig. 2A). More than 80% of those  T 
cells expressed the activation marker HLA-DR, which is generally negative in normal  
T cells (Fig. 2B). The ratio of CD4+ to CD8+ T cells and the percentage expression of 
CD45RO+ memory marker in CD4+ and CD8+ T cells were normal in all patients (data 
not shown). 
 
Clonal expansion of V9+ V2+  T cells 
We next analyzed the diversity of the TCR V repertoire in  T cells from the 
patients using V-specific mAbs and CDR3 spectratyping. Flow cytometric analysis 
clearly demonstrated a massive expansion of TCR V2+ cells among the  T cells from 
these patients (Fig. 2A). In age-matched controls, CDR3 spectratyping of the TCR V1, 
2, and 3 segments exhibited a Gaussian curve reflecting the polyclonal V repertoire 
(Fig. 3A). Although all 3 V segments were amplified from the patients’ cDNA, 
preferential usage of TCR V2 was seen on their gel images in the patients compared 
with controls (data not shown). Quantitative RT-PCR analysis showed that the levels of 
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V2 mRNA in PBMCs from the patients were much higher than those in PBMCs from 
controls (Fig. 3B). CDR3 spectratyping of their TCR V2 segments exhibited a single 
peak, whereas their V1 and V3 segments exhibited polyclonal peaks (Fig. 3A). The 
junctional amino acid sequence of their TCR V2 segments also exhibited monoclonal 
profiles (Table 1). The clonally expanded  T cells of patients 1, 2 and 3 were V2-J2+, 
V2-J1+, V2-J3+ cells, respectively. We also analyzed mRNA of TCR V1, V4 and 
V9. Similar to those found in TCR V, the patients’ TCR V9 segments were 
preferentially amplified (data not shown), and showed monoclonal profiles (Fig. 3C). 
Consistent with these monoclonal TCR V and V9 patterns, Southern blot analysis of 
EBV terminal repeats showed monoclonal EBV in the peripheral blood from all patients 
(data not shown). 
 
Skin infiltration of V2+  T cells 
The availability of skin biopsy specimens from patient 1 offered us the unique 
opportunity to investigate whether the clonally expanded  T cells existed in the HV-like 
eruptions. Although the V clones obtained from her skin lesion included only V2, the 
V2 segments exhibited a couple of different J. Of note, we were able to show that one 
of those V clones were identical to that of the clonally expanded V2-J2+  T cells in 
the peripheral blood (Fig. 4, Table 1). These results suggested that EBV-infected V2+  





HV has been recently reported to be pathogenically associated with chronic latent 
EBV infection [7-9]. It is also known that patients with CAEBV may present with various 
cutaneous manifestations including HV-like eruptions [3]. CAEBV patients with HV-like 
eruptions sometimes develop cutaneous T-cell lymphoma that is defined as HV-like 
lymphoma in the 2008 World Health Organization classification of lymphoid neoplasms 
[19]. This condition is increasingly being described in children and adolescents from Asia 
or Latin America [19]. In these diseases, the EBV-infection is usually thought to occur in 
T or NK cells, however, precise immunophenotyping and clonality of those cells remains 
to be elucidated [7-9].  
In the present study, we demonstrated ectopic EBV infection of  T cells and 
increased subpopulations of  T cells in the peripheral blood in 3 patients with CAEBV. 
Interestingly, two of them showed HV-like eruptions. These results were in agreement 
with recent studies that demonstrated associations between HV and increased numbers of 
EBV-infected  T cells [10-12]. In addition, we found that circulating  T cells were in 
a highly-activated state in our patients. In normal individuals,  T cells usually comprise 
a small proportion of the circulating lymphocyte population. Expansion of the  T-cell 
subset has been also documented in the context of various infections including 
Mycobacterium and cytomegalovirus [20]. However, selective activation and expansion 
of  T cells may provide us with clinical clues to suspect ectopic EBV infection of  T 
cells in children suffering from HV or lymphoproliferative disease. Further investigations 
are necessary to clarify the major cellular targets of EBV infection and to understand the 
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pathophysiological link between ectopic EBV infection and the clinical manifestations of 
the disease.  
There was clear evidence of clonal expansion of V9+ V2+  T cells in our 
patients. We assume that the EBV infection predominantly targeted V9+ V2+  T cells 
and expanded clonally in the patients. Human  T cells exhibit a restricted repertoire 
using a limited set of V and V gene elements compared with  T cells. There are only 
6 functional V and 8 functional V genes in human [21]. At birth, the repertoire of  T 
cells in cord blood is broad with no apparent restriction [22]. However, the initially small 
subset of V9+ V2+ cells has been shown to gradually increase with age, resulting in a 
high frequency of polyclonal V9+ V2+ cells in adult peripheral blood [23]. Although 
careful interpretation of the results of monotypic V9/V2 domain expression is needed, 
in our cases the predominance of V9+ V2+  T cell was not likely to be age-dependent. 
The absolute counts of V2+  T cells, as well as the V2 mRNA levels, in PBMCs were 
strikingly elevated in our young patients. CDR3 spectratyping of their V2 segments 
showed monoclonal peaks that were confirmed by sequence analysis. In addition, 
Southern blot analysis of EBV terminal repeats indicated monoclonal EBV infection. On 
the other hand, studies of T cell lines established from 3 patients with nasal T-cell 
lymphoma or CAEBV have also indicated preferential expansion of EBV-infected 
V9/V2  T cells [24]. However, these and our results are insufficient to allow us to 
draw any conclusion regarding higher susceptibility to EBV infection of V9+ V2+  T 
cells compared with other  T cells. Frequent identification of EBV-infected V9+ V2+ 
 T cells could simply be due to a higher percentage of V9/V2  T cells at the time of 
infection. The mechanism underlying the ectopic infection also remains elusive. 
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In patient 1, we have previously demonstrated that approximately 25% of the cells 
infiltrating into the HV-like eruptions were EBV positive by in situ hybridization for 
EBER-1, and that about 30% of the infiltrating cells appeared to be CD3+ CD4- CD8- T 
cells by immunohistochemical analysis [13]. However, the presence of EBV-infected  
T cells in the skin could not be confirmed because of the lack of a suitable anti-TCR  
antibody for paraffin-embedded tissues. In the present study, our molecular analysis 
clearly demonstrated the skin infiltration of V2+  T cells, which were identical to the 
clonally expanded V2+  T cells in the peripheral blood and were thus infected by EBV 
in this patient. In normal individuals,  T cells take residence mainly in epithelial tissues, 
such as skin, and represent the major T-cell population there, and modulate epithelial 
homeostasis through their cytokine secretion and cytolytic properties [25]. It is well 
known that skin lesions of HV can be induced by repeated ultraviolet exposure [26]. 
Studies in a murine model for drug-induced cutaneous lupus erythematosus demonstrated 
that ultraviolet might enhance the function of skin  T cells that were involved in skin 
lesions [27]. Therefore, EBV-infected  T cells may play an important role in the skin 
lesions of HV. Additional investigation will be required to assess whether the presence of 
EBV-infected  T cells in the skin lesions results from ectopic EBV infection into skin-
resident  T cells or migration of EBV-infected  T cells from peripheral blood after 
sun exposures. 
 In summary, our studies demonstrate clonal expansion of EBV-infected  T cells 
in  T cell-type CAEBV, further support the association between EBV-infected  T 
cells and HV, and provide the basis for characterization of EBV-infected cells to better 
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Table 1. Junctional amino acid sequences of  T cells 
 
       DV    N-D-N                DJ   Frequency 
PBMCs, V2 
 Control YCACD SLNRGTSRD TDKLIFGKGTRVTVEPR  1/18 
  YCACD TVGGPD YTDKLIFGKGTRVTVEPR  1/18 
  YCACDT GFGGILS SWDTRQMFFGTGIKLFVEPR  1/18 
  YCACD SLGDTPP YTDKLIFGKGTRVTVEPR  1/18 
  YCACDT VGGSVPES YTDKLIFGKGTRVTVEPR  1/18 
  YCAC EPLGGGYY YTDKLIFGKGTRVTVEPR  1/18 
  YCACDT LQ YTDKLIFGKGTRVTVEPR  1/18 
  YCACD TVRGSVLGDTL TDKLIFGKGTRVTVEPR  1/18 
  YCACD IWGNA DKLIFGKGTRVTVEPR  1/18 
  YCACD ILGTGA DKLIFGKGTRVTVEPR  1/18 
  YCAC VGLGAH DKLIFGKGTRVTVEPR  1/18 
  YCACDT VELGDPTV TDKLIFGKGTRVTVEPR  1/18 
  YCACD PVGVT YTDKLIFGKGTRVTVEPR  1/18 
  YCACD FILTRGIS KLIFGKGTRVTVEPR  1/18 
  YCACD PLRTGGHS DKLIFGKGTRVTVEPR  1/18 
  YCACD TAGRA YTDKLIFGKGTRVTVEPR  1/18 
  YCAC VPLLGNH DKLIFGKGTRVTVEPR  1/18 
  YCACD LLGDDEGY KLIFGKGTRVTVEPR  1/18 
 
 Patient 1 YCACD ILGD MTAQLFFGKGTQLIVEPG  24/24 
 
 Patient 2 YCACD SLTGGF TDKLIFGKGTRVTVEPR  25/27 
  YCACD SLAGGF TDKLIFGKGTRVTVEPR  1/27 
  YCACG SLTGGF TDKLIFGKGTRVTVEPR  1/27 
 
 Patient 3 YCACD TGGYA SWDTRQMFFGTGIKLFVEPR   27/30 
  YCACD TGGYA SWDARQMFFGTGIKLFVEPR  1/30 
  YCACD TGGYA SWDTRQMLFGTGIKLFVEPR  1/30 
  YCACD TGGYA SWDTRQMFIGTGIKLFVEPR  1/30 
 
Skin, V2-J2 








Figure 1. Characterization of EBV-infected cells 
(A) Detection of EBER-1+ cells in  T cells from patient 3. (B-D) Frequency of EBV-
infected cells. The percentage of EBER-1+ cells within the patients’ lymphocyte subsets 
are shown in patient 1 (b), patient 2 (c), and patient 3 (d). 
 
Figure 2. Immunophenotype of  T cells 
(A) Expression profiles of T-cell receptor (TCR) V subfamilies. Peripheral blood 
samples were stained with mAbs for anti-TCR V1 or anti-TCR V2 together anti-TCR 
Pan  mAb. The percentage of cells was analyzed by flow cytometry and expressed with 
respect to the total lymphocyte population. (B) Activation status of  T cells. Expression 
of HLA-DR was evaluated in  T cells. 
 
Figure 3. CDR3 spectratyping and TCR V2 mRNA copies 
(A) CDR3 size distribution of TCR V. Each TCR V fragment was amplified from the 
cDNA with specific primers. The size distribution of the polymerase chain reaction 
(PCR) products was determined by an automated sequencer and GeneScan software. (B) 
TCR V2 mRNA was determined by real-time quantitative RT-PCR. Data was 
normalized to -actin expression and represent the mean (± standard deviation) of 3 
independent experiments. (C) CDR3 size distribution of TCR V. Each TCR V fragment 
was amplified from the cDNA with specific primers. 
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Figure 4. TCR V genomic sequences in the skin lesion from patient 1 
(A) Each TCR V fragment was amplified from skin DNA with one of 6 TCR V-
specific forward primers and a combination of 4 TCR J-specific reverse primers. (B) 
Each TCR J fragment was amplified with the TCR V2-specific forward primer and one 
of 4 TCR J-specific reverse primers. Lane M, 100-bp molecular marker. 
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